New Option for Psoriasis Treatment Just Approved!

Good news for those that suffer from psoriasis – a chronic, inflammatory genetic immune condition. A new biologic COSENTYX was just approved by the FDA for the treatment of moderate to severe psoriasis.

This medication works by blocking a specific component of the immune system called IL-17. By doing so, the drug decreases inflammation caused by psoriasis and improves the patients skin. In studies. over 65% of patients were clear or almost clear after 12 – 16 weeks of treatment.

While like all systemic medications, cosentyx has some potential side effects, with careful lab monitoring and follow up, the drug can be used safely.

Screen Shot 2015-01-31 at 5.07.06 PM

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply